You have 9 free searches left this month | for more free features.

City

Baltimore (1)

Berlin-Spandau (1)

Condition

Asthma (1)

Chronic Obstructive Pulmonary Disease (1)

Chronic Obstructive Pulmonary Disease (COPD) (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 4 (1)

Sponsor

Chiesi Farmaceutici S.p.A. (2)

Collaborator

Intervention

chf5993 (2)

chf1535 (1)

chf5259 (1)

chf5993 placebo (1)

matched placebo (1)

moxifloxacin 400mg (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

chf5993

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)

Recruiting

Asthma
Chronic Obstructive Pulmonary Disease (COPD)

CHF5993
+3 more

Baltimore, Maryland

PAREXEL Baltimore Early Phase Clinical Unit

Apr 13, 2023

COPD Trial in Berlin-Spandau (CHF5993, CHF1535, Matched )

Recruiting

Chronic Obstructive Pulmonary Disease

CHF5993
+2 more

Berlin-Spandau, Berlin Spandauer Damm, Germany

PAREXEL International GmbH Early Phase Clinical Unit Berlin

Jan 21, 2022